{
    "eid": "2-s2.0-85113725980",
    "title": "Human metapneumovirus and parainfluenza virus infections in lung transplant recipients: The effects on lung allograft and clinical outcomes",
    "cover-date": "2021-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Transplantation",
            "@code": "2747",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Nitipong Permpalung",
        "Afrah S. Sait",
        "Katrina Bazemore",
        "Robin K. Avery",
        "Joby Mathew",
        "Pali D. Shah"
    ],
    "citedby-count": 9,
    "ref-count": 20,
    "ref-list": [
        "Community respiratory virus infections following lung transplantation",
        "A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients",
        "Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death",
        "Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus",
        "Incidence and morbidity of human metapneumovirus and other community-acquired respiratory viruses in lung transplant recipients",
        "Human metapneumovirus in severe respiratory syncytial virus bronchiolitis",
        "Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment",
        "The role of human parainfluenza virus infections in the immunopathology of the respiratory tract",
        "Pathogenesis of human parainfluenza virus 3 infection in two species of cotton rats: Sigmodon hispidus develops bronchiolitis, while Sigmodon fulviventer develops interstitial pneumonia",
        "Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients",
        "Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study",
        "Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology",
        "Symptomatic respiratory virus infection and chronic lung allograft dysfunction",
        "Evaluation of 10 years of parainfluenza virus, human metapneumovirus, and respiratory syncytial virus infections in lung transplant recipients",
        "Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study",
        "American Society of Transplantation Infectious Diseases Community of Practice. RNA respiratory viral infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice",
        "Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection",
        "Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation",
        "An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome",
        "Oral and inhaled ribavirin treatment for respiratory syncytial virus infection in lung transplant recipients"
    ],
    "affiliation": [
        {
            "affiliation-city": "Baltimore",
            "@id": "60001117",
            "affilname": "Johns Hopkins School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001117",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Ansun Biopharma",
        "Takeda/Shire",
        "National Institute of Health",
        "Cystic Fibrosis Foundation",
        "Astellas",
        "Merck",
        "Health Systems Research Institute",
        "Aicuris"
    ]
}